WallStSmart

Churchill Capital Corp XI (CCXI)vsSoren Acquisition Corp. Class A Ordinary Shares (SORN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

SORN leads profitability with a 0.0% profit margin vs 0.0%. SORN earns a higher WallStSmart Score of 24/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

SORN

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 5.0Quality: 6.0
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

SORN0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$677.31M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

SORN4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$344.56M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : SORN

SORN has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : SORN

The primary concerns for SORN are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

SORN is growing revenue faster at 0.0% — sustainability is the question.

CCXI generates stronger free cash flow (-326,107), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (24/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Soren Acquisition Corp. Class A Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

Soren Acquisition Corp. (Ticker: SORN) is a dedicated special purpose acquisition company (SPAC) focused on identifying and merging with high-growth enterprises across various sectors. Leveraging the extensive operational experience and due diligence expertise of its management team, SORN seeks strategic acquisitions that promise to enhance long-term shareholder value. The company is committed to channeling its capital towards innovative businesses positioned for significant market expansion and operational efficiencies, representing a compelling opportunity in the dynamic SPAC environment.

Want to dig deeper into these stocks?